Infectious Disease Testing Demand Strengthens Global IVD Industry Outlook
Mar 20
<p>The global <strong><a href="https://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html">in vitro diagnostics market</a></strong> was valued at USD 91.2 billion in 2022 and is projected to surpass USD 119.7 billion by the end of 2031, expanding at a CAGR of 5.3% from 2023 to 2031. Market growth is driven by the rising prevalence of chronic and infectious diseases, increasing demand for early and accurate diagnostic solutions, and continuous advancements in diagnostic technologies. Additionally, the growing adoption of point-of-care testing and expanding healthcare infrastructure across emerging economies are further supporting market expansion.</p><p><strong>Dive Deeper into Data: Get Your In-Depth Sample Now! <a href="https://www.transparencymarketresearch.com/sample/sample.php?flag=S&amp;rep_id=1395">https://www.transparencymarketresearch.com/sample/sample.php?flag=S&amp;rep_id=1395</a> </strong></p><p>Reagent and kit consumption, along with high-throughput laboratory automation, play a decisive role in market dynamics. As the global healthcare sector pivots toward value-based care, manufacturers are focusing on multiplex assays and high-sensitivity diagnostics. Sustainable and cost-effective testing platforms are gaining significant traction, particularly in emerging economies. For major diagnostic players, maintaining a robust R&D pipeline for molecular diagnostics and companion diagnostics has become a top priority to address the rising burden of chronic illnesses.</p><p>Advancements in next-generation sequencing (NGS) and lab-on-a-chip technologies have enabled the development of highly precise diagnostic tools with shorter turnaround times. Beyond infectious disease screening, new design innovations are targeting the complex needs of oncology and autoimmune disorder management. The development of specialized digital pathology and AI-driven image analysis is particularly vital for enhancing the accuracy of tissue diagnostics and liquid biopsies.</p><p>Next-generation IVD is moving toward "hospital-at-home" models, where user-friendly, connected devices provide real-time health data to clinicians. This shift toward digital health integration not only improves patient outcomes but also optimizes laboratory throughput by reducing the reliance on central facilities for routine monitoring. As the industry embraces a more personalized approach, there is an increasing focus on pharmacogenomics to tailor drug therapies to individual genetic profiles.</p><p><strong>Key Findings of the Market Report</strong></p><ul><li>Based on product, the <strong>reagents and kits</strong> segment held a dominant market share of approximately 65.8% in 2023, driven by high testing volumes and recurring demand.</li><li>The <strong>molecular diagnostics</strong> segment is projected to register the highest growth rate, fueled by breakthroughs in genomic testing and the transition to decentralized IVD applications.</li><li>Demand for <strong>infectious disease</strong> testing continues to lead the application landscape, though oncology and cardiology are emerging as high-growth sectors.</li><li><strong>North America</strong> accounted for the largest revenue share in 2023, while the <strong>Asia-Pacific</strong> region is expected to witness the highest CAGR through 2032 due to improving healthcare infrastructure.</li></ul><p><strong>Global In Vitro Diagnostics Market: Growth Drivers</strong></p><ul><li><strong>Rising Prevalence of Chronic Diseases:</strong> The global increase in cancer, diabetes, and cardiovascular conditions is a primary driver, necessitating frequent and accurate diagnostic monitoring.</li><li><strong>Expansion of Point-of-Care (POC) Testing:</strong> Technological shifts toward portable and rapid diagnostic devices are improving accessibility in primary care and home-based settings.</li><li><strong>Aging Global Population:</strong> A rapidly growing geriatric demographic, more prone to complex health conditions, is significantly uplifting the demand for routine laboratory testing.</li><li><strong>Personalized Medicine Trends:</strong> The shift from a "one-size-fits-all" approach to tailored treatment protocols is driving the adoption of companion diagnostics and genetic markers.</li></ul><p><strong>Global In Vitro Diagnostics Market: Regional Landscape</strong></p><ul><li><strong>North America</strong> leads the global market, supported by a highly developed healthcare system, favorable reimbursement policies, and a strong presence of major diagnostic OEMs.</li><li><strong>Asia-Pacific</strong> is forecasted to be the fastest-growing region. Rapid urbanization, increasing healthcare expenditure per capita, and government initiatives to modernize diagnostic labs in China and India are fueling this growth.</li><li><strong>Europe</strong> maintains a significant share, with a heavy focus on regulatory compliance (IVDR) and the integration of digital health and AI solutions into public health planning.</li></ul><p><strong>Buy this Premium Research Report: <a href="https://www.transparencymarketresearch.com/checkout.php?rep_id=1395&amp;ltype=S">https://www.transparencymarketresearch.com/checkout.php?rep_id=1395&amp;ltype=S</a> </strong></p><p><strong>Global In Vitro Diagnostics Market: Key Players</strong></p><p>Major diagnostic manufacturers are employing strategic acquisitions and automation-focused partnerships to enhance their market presence and operational efficiency.</p><ul><li><strong>F. Hoffmann-La Roche Ltd.</strong></li><li><strong>Abbott Laboratories</strong></li><li><strong>Danaher Corporation (Beckman Coulter / Cepheid)</strong></li><li><strong>Siemens Healthineers AG</strong></li><li><strong>Thermo Fisher Scientific Inc.</strong></li><li><strong>Becton, Dickinson and Company (BD)</strong></li><li><strong>bioMérieux SA</strong></li><li><strong>Sysmex Corporation</strong></li><li><strong>Qiagen N.V.</strong></li><li><strong>Bio-Rad Laboratories, Inc.</strong></li></ul><p><strong>Global In Vitro Diagnostics Market: Segmentation</strong></p><p><strong>By Product & Service</strong></p><ul><li>Reagents & Kits</li><li>Instruments</li><li>Software & Services</li></ul><p><strong>By Technology</strong></p><ul><li>Immunoassay/Immunochemistry</li><li>Clinical Chemistry</li><li>Molecular Diagnostics</li><li>Hematology</li><li>Microbiology</li><li>Coagulation & Hemostasis</li><li>Others</li></ul><p><strong>By Application</strong></p><ul><li>Infectious Diseases</li><li>Oncology</li><li>Cardiology</li><li>Diabetes</li><li>Autoimmune Diseases</li><li>Nephrology</li><li>Drug Testing</li></ul><p><strong>By End User</strong></p><ul><li>Hospitals & Clinics</li><li>Diagnostic Laboratories</li><li>Academic & Research Institutes</li><li>Home Care Settings</li><li>Others</li></ul><p><strong>About Transparency Market Research</strong></p><p><strong>Transparency Market Research</strong>, a global <a href="https://www.globenewswire.com/Tracker?data=MKyRdE0P94ioyU9f_0pp_wK0uV5-pktG40_qdemb39yORO5ij1UiDsjS3kZVPgI-OU0u348INknIe5Axs0iEQkizjjMb2WGH24rFxKRmG66df6VI3JqcmmcboAodjufF"><strong>market research company</strong></a> registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.</p><p>Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.</p><p><strong>Media Contact:</strong></p><p>Abhishek Budholiya<br /><strong>Transparency Market Research Inc.</strong><br />State Tower, 90 State Street, Suite 700,<br />Albany NY - 12207, United States<br />Tel: +1-518-618-1030<br />USA – Canada Toll Free: 866-552-3453<br /><strong>Website: <a href="https://www.transparencymarketresearch.com">https://www.transparencymarketresearch.com</a> <br />Media Inquiries: <a href="mailto:media@transparencymarketresearch.com">media@transparencymarketresearch.com</a><br />Sales Inquiries: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></strong></p>